2-甲基-6-喹啉甲酸 | 3416-18-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2-甲基-6-喹啉甲酸
• 中文别名: 5-羟基吲哚酮；2,3-二氢-5-羟基吲哚-2-酮；5-羟基吲哚-2-酮；5-羟基氧化吲哚
• 英文名称: 5-hydroxyoxindole
• 英文别名: 5-hydroxyindolin-2-one；5-hydroxy-2-oxindole；5-Hydroxy-oxindol；5-hydroxy-1,3-dihydro-indol-2-one；5-hydroxy-1,3-dihydroindol-2-one
• CAS: 3416-18-0
• 化学式: C₈H₇NO₂
• mdl: MFCD00014566
• 分子量: 149.149
• InChiKey: ZGTUSQAQXWSMDW-UHFFFAOYSA-N

物化性质

• 熔点：
  156-157 °C(Solv: ethanol (64-17-5))
• 沸点：
  419.9±45.0 °C(Predicted)
• 密度：
  1.362±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2933790090
• WGK Germany：
  3
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H317,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Hydroxyoxindole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Hydroxyoxindole
CAS number: 3416-18-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H7NO2
Molecular weight: 149.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

2-甲基-6-喹啉甲酸用作研究用化合物。

反应信息

• 作为反应物：
  描述：

  2-甲基-6-喹啉甲酸 在 碳酸氢钠 、 potassium hydroxide 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 7.0h， 生成 5-methoxy-1-(tert-butoxycarbonyl)oxindole
  参考文献：
  名称：

  Regioselective Synthesis of Heteroaryl Triflones by LDA (Lithium Diisopropylamide)-Mediated Anionic Thia-Fries Rearrangement

  摘要：

  Novel heteroaryl triflones including oxindole, pyrazolone, pyridine, and quinoline derivatives have been regioselectively synthesized by LDA-mediated thia-Fries rearrangement for the first time. These reactions are also the first examples of the application of anionic thia-Fries rearrangement in heteroaromatic compounds.

  DOI：

  10.1021/ol300842d
• 作为产物：
  描述：

  6-甲氧基-2-氧化吲哚 在 水 、 氢溴酸 作用下， 反应 16.0h， 以65%的产率得到2-甲基-6-喹啉甲酸
  参考文献：
  名称：

  [EN] LRRK2 INHIBITORS
  [FR] INHIBITEURS DE LRRK2

  摘要：

  公开号：

  WO2012178015A3

文献信息

• Kinase inhibitors
  申请人：Amgen Inc.

  公开号：US20040116388A1

  公开（公告）日：2004-06-17

  The invention relates to inhibitors of enzymes that bind to ATP or GTP and/or catalyze phosphoryl transfer, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making phosphoryl transferase inhibitor compounds, methods of inhibiting phosphoryl transferase activity, and methods for treating disease or disease symptoms.

  这项发明涉及与ATP或GTP结合并/或催化磷酸转移的酶的抑制剂，包括这些抑制剂的组合物，以及使用这些抑制剂和抑制剂组合物的方法。这些抑制剂和包含它们的组合物对治疗疾病或疾病症状是有用的。该发明还提供了制备磷酸转移酶抑制剂化合物的方法，抑制磷酸转移酶活性的方法，以及治疗疾病或疾病症状的方法。
• Compounds And Compositions for the Treatment of Ocular Disorders
  申请人：Graybug Vision, Inc.

  公开号：US20170080092A1

  公开（公告）日：2017-03-23

  The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.

  该披露描述了前药和前列腺素的衍生物、碳酸酐酶抑制剂、激酶抑制剂、β-肾上腺素受体拮抗剂和其他药物，以及含有这些前药和衍生物的受控释放配方，用于治疗眼部疾病。
• [EN] MACROCYCLES AND THEIR USE<br/>[FR] MACROCYCLES ET LEUR UTILISATION
  申请人：BLOSSOMHILL THERAPEUTICS INC

  公开号：WO2022011123A1

  公开（公告）日：2022-01-13

  The present disclosure relates to macrocyclic compounds, pharmaceutical compositions containing macrocyclic compounds, and methods of using macrocyclic compounds to treat disease, such as cancer.

  本公开涉及大环化合物、含有大环化合物的药物组合物，以及利用大环化合物治疗疾病（如癌症）的方法。
• Synthesis of 3-[4-(dimethylamino)phenyl]alkyl-2-oxindole derivatives and their effects on neuronal cell death
  作者：Kyoji Furuta、Yu Kawai、Yosuke Mizuno、Yurika Hattori、Hiroko Koyama、Yoko Hirata

  DOI：10.1016/j.bmcl.2017.08.005

  日期：2017.9

  oxindole skeleton by anion-based methods provided additional substituted derivatives for structure-activity relationship studies. Their effects on neuronal cell death induced by oxidative stress were evaluated by lactate dehydrogenase assay. Compounds with the alkyl chain length of 2–4 significantly suppressed the neuronal cell death. No significant change occurred in the activity by substitution with

  通过以下两种途径之一合成了新型3- [4-（二甲基氨基）苯基]烷基-2-氧吲哚类似物：（1）羟吲哚与（4-二甲基氨基）肉桂醛加氢的Knoevenagel缩合序列，或（2 ）用[（4-二甲基氨基）苯基]烷基卤化物对羟吲哚二价阴离子进行烷基化。随后通过基于阴离子的方法在羟吲哚骨架的C-3和/或N-1处进行烷基化，为结构-活性关系研究提供了额外的取代衍生物。通过乳酸脱氢酶测定评估它们对氧化应激诱导的神经元细胞死亡的影响。烷基链长为2-4的化合物可显着抑制神经元细胞死亡。通过用极性较小的基团取代，活性没有发生显着变化。
• Synthesis and Reactivity of 3,3-Diazidooxindoles
  作者：Kristina Holzschneider、Fabian Mohr、Stefan F. Kirsch

  DOI：10.1021/acs.orglett.8b03013

  日期：2018.11.16

  mild and simple conditions with NaN3 and iodine, in good yields. The notable reactivity of this new class of compounds toward primary and secondary nucleophilic amines is also described, which gives access to either 4-imino-3,4-dihydroquinazolin-2(1H)-one derivatives or cyanophenylureas.

  通过2-氧吲哚的直接氧化二叠氮化反应，合成了以前未知的3，3-二氮杂恶吲哚类化合物，它们是合成的有用的靛红衍生物。该方法在温和简单的条件下，由起始的吲哚与NaN 3和碘，以良好的收率得到了重氮基化合物。还描述了这类新化合物对伯亲核胺和仲亲核胺的显着反应性，从而可以使用4-亚氨基-3,4-二氢喹唑啉-2（1 H）-一衍生物或氰基苯基脲。

表征谱图